CAS
CTIC

CTC Alternative Strategies’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

CTC Alternative Strategies’s Portfolio CTIC Stock Details CTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-10,730
Closed -$113K – 243
2013
Q2 		$113K Buy
+10,730
New +$126K 0.03% 164

Other funds holding CTIC

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

CTC Alternative Strategies's CTIC Position: Q3 2013 in Review

CTC Alternative Strategies sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q3 2013, closing a stake of 10,730 shares — an estimated $113K sold.

CTC Alternative Strategies first reported a position in CTIC in Q2 2013 and held it in 1 quarter. The position peaked at $113K in Q2 2013. 67 funds tracked by Wall St. Rank hold CTIC as of Q3 2013.

  • CTC Alternative Strategies reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q3 2013 after selling out during the quarter.
  • CTC Alternative Strategies sold 10,730 CTI BioPharma Corp. (DE) Common Stock shares in Q3 2013, an estimated $113K.
  • CTC Alternative Strategies first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q2 2013 and held it in 1 quarter.
  • CTC Alternative Strategies's CTI BioPharma Corp. (DE) Common Stock position peaked at $113K in Q2 2013.
  • 67 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q3 2013.

Based on CTC Alternative Strategies's 13F filing for Q3 2013, filed 31 Oct 2013.